SMARCA4 and neoplasm: Mutations of BRG1 and silencing of BRG1 protein expression have been observed in several cancers; moreover, BRG1−/+ in heterozygous mice has led to increased tumor development, suggesting that BRG1 may act as a tumor suppressor [11, 12].